Equities

Chemometec A/S

Chemometec A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)315.20
  • Today's Change-3.40 / -1.07%
  • Shares traded37.07k
  • 1 Year change-38.80%
  • Beta1.6768
Data delayed at least 15 minutes, as of Jun 14 2024 16:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

  • Revenue in DKK (TTM)401.54m
  • Net income in DKK143.80m
  • Incorporated1997
  • Employees171.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
WuXi Xinje Electric Co Ltd1.46bn194.59m4.44bn2.20k22.822.15--3.051.441.4410.7915.320.51861.669.83688,861.206.9311.279.6014.9436.7537.1513.3620.592.03--0.146812.6812.7320.58-10.376.0136.267.96
Siglent Technologies Co Ltd465.84m143.88m4.75bn462.0032.873.10--10.200.94490.94493.0610.010.29020.93966.331,049,530.008.9610.799.4711.6461.5657.6930.8929.2314.52--0.02360.2221.5025.6810.2939.9675.52--
ChemoMetec A/S401.54m143.80m5.49bn171.0038.1511.0033.8213.668.268.2623.0728.660.69820.80646.012,448,421.0025.0030.4329.6938.9978.8579.4435.8134.173.37--0.011846.903.7431.5812.0457.8819.91--
Standard Biotools Inc883.63m-947.92m5.54bn534.00--1.42--6.27-0.9957-0.99570.95371.520.22062.055.02237,380.20-15.66-28.17-18.29-33.6049.1551.58-70.98-74.854.17--0.0869--8.57-1.2060.73--50.06--
Suzhou Veichi Electric Co Ltd1.30bn193.71m5.80bn1.42k27.583.04--4.481.041.046.859.440.63022.912.99948,722.109.3610.4113.0714.7537.8336.1614.8514.781.75--0.08226.1444.0329.6036.4040.1658.99--
Judges Scientific PLC1.20bn84.01m5.96bn714.0073.588.1526.644.951.381.3820.5612.460.7371--5.37190,616.305.3610.167.4914.75--65.727.2711.151.115.190.441564.7320.2211.81-23.622.2643.9418.89
Guodian Nanjing Automation Co., Ltd.7.43bn231.16m6.05bn3.61k29.062.02--0.8150.2560.2568.283.680.81524.302.132,144,556.004.493.6312.9311.2723.4624.395.515.431.0819.510.13636.608.789.1048.9834.168.4621.98
Suzhou TZTEK Technology Co Ltd1.59bn202.34m6.31bn2.05k32.063.51--3.961.061.068.579.720.51761.003.62811,397.706.576.039.918.4740.8241.0112.6911.520.9966--0.298749.723.7026.5241.4617.9031.24--
SAM Engineering & Equipment (M) Bhd2.21bn160.38m6.50bn1.97k33.633.0723.812.940.19330.19332.662.120.81492.872.32--5.916.778.9710.1715.4512.927.256.991.395.370.181421.753.6014.6822.216.70-1.25-5.09
Data as of Jun 14 2024. Currency figures normalised to Chemometec A/S's reporting currency: Danish Krone DKK

Institutional shareholders

40.28%Per cent of shares held by top holders
HolderShares% Held
BlackRock Investment Management (UK) Ltd.as of 13 Jun 20241.67m9.62%
Invesco Advisers, Inc.as of 16 May 2023881.14k5.06%
Swedbank Robur Fonder ABas of 31 May 2024754.00k4.33%
Handelsbanken Fonder ABas of 31 May 2024642.14k3.69%
Fj�rde AP-fondenas of 31 Dec 2023600.00k3.45%
The Vanguard Group, Inc.as of 06 Jun 2024572.45k3.29%
SEB Investment Management AB (Denmark)as of 31 May 2024561.92k3.23%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 28 Mar 2024460.00k2.64%
Fidelity Management & Research Co. LLCas of 30 Apr 2024452.86k2.60%
Norges Bank Investment Managementas of 31 Dec 2023411.11k2.36%
More ▼
Data from 31 Dec 2023 - 31 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.